The Ever-Expanding T-Cell World: A PrimerThe ScientistIn another approach, chimeric antigen receptor (CAR) T-cell therapy, researchers engineer T cells to carry receptors that bind directly to a surface protein on a tumor cell and transfer the modified… Continue reading
Kite Pharma (KITE) Initiates Axicabtagene Ciloleucel CAR-T Clinical Program in EUStreetInsider.comKite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that patients in the European Union (EU) are now being treated with its … Continue reading
FierceBiotech |
Bluebird Bio sees Europe as first market for its gene therapies
FierceBiotech Bluebird Bio plans to bring its gene therapies to market in Europe before the U.S., thanks to a favorable regulatory pathway. Bluebird’s vice president for immunotherapy, Richard Morgan, told the Daily Telegraph that the company is already in … |